BOSTON – Results from a randomized clinical trial of 127 patients with symptomatic atrial fibrillation (AF) from around the world show that pulmonary vein isolation (PVI) with radiofrequency ablation is safe and significantly superior to the current first-line therapy approach of antiarrhythmic drugs (AAD), as reported today from Heart Rhythm 2012, the Heart Rhythm Society’s 33rd Annual Scientific Sessions.
Showing all archived press releases starting with 2014. Back
BOSTON – A study of more than 350 competitive athletes with implantable cardioverter defibrillators (ICDs) from around the world showed for the first time that sports may be safer for this group than has been thought. There were no occurrences of death or injury due to arrhythmia or shock during sports in this group. Additionally, only ten percent of the athletes received a shock during competition or practice and of those, most continued to play, as reported today at Heart Rhythm 2012, the Heart Rhythm Society’s 33rd Annual Scientific Sessions.
BOSTON – Initial results from the International Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS (EFFORTLESS) subcutaneous implantable defibrillator (S-ICD System) Registry shows that the latest heart device, the S-ICD System, is performing appropriately in real-world circumstances and continues to show positive results in patients. Data analyzed from the largest study of real world experience using the S-ICD System to-date, demonstrated a conversion rate >98% for induced and ambulatory ventricular tachycardia or fibrillation (VT/VF), consistent with transvenous ICD systems.
BOSTON – A study presented today at Heart Rhythm 2012, the Heart Rhythm Society’s 33rd Annual Scientific Sessions, reports that Black Africans are 50 percent less likely to develop atrial fibrillation (AF) than White Europeans, despite greater prevalence of risk factors, such as heart failure, diabetes, prior stroke and left ventricular hypertrophy. For the first time, this analysis of a large population of patients with an implanted dual-chamber pacemaker shows that genetic and/or environmental factors affect the incidence of AF.
BOSTON – For the first time, a significant and direct correlation has been shown between the specific region of the body where obese individuals carry their weight and the increased risk of sudden cardiac death (SCD). Specifically, obese individuals with an “apple” shape figure, or larger waste-to-hip ratio (WHR), are at greater risk than those with a more “pear” shaped figure, or smaller WHR.
BOSTON – Today, Heart Rhythm 2012, the Heart Rhythm Society’s 33rd Annual Scientific Sessions and this year’s premier conference on cardiac arrhythmias, begins at the Boston Convention & Exhibition Center. The meeting is the most comprehensive educational event on heart rhythm disorders, offering more than 250 educational opportunities, over 130 exhibits and seven specialty tracks in the heart rhythm management field. This year’s focus of Heart Rhythm 2012 is on “Our Patients”, and showcases the latest science, discovery and innovation that are essential to improving the quality care for patients.
BOSTON – Late-Breaking Clinical Trials will be revealed at Heart Rhythm 2012, the Heart Rhythm Society’s 33rd Annual Scientific Sessions.
BOSTON – The Heart Rhythm Society will host press events with Society leadership and other experts in the medical field at Heart Rhythm 2012, the Heart Rhythm Society’s 33rd Annual Scientific Sessions. These events will take place in addition to the regularly scheduled sessions for each day.
WASHINGTON — Black patients with high blood pressure, also known as hypertension, have a twofold risk of sudden cardiac death (SCD) regardless of other common risk factors such as age, gender, family history and pre-existing heart disease, according to the Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study. The LIFE study, published in the April edition of HeartRhythm, the official journal of the Heart Rhythm Society, is the first study to show a direct correlation between race and the risk of SCD in hypertensive patients after adjusting for multiple factors.
WASHINGTON — The Accreditation Council for Continuing Medical Education (ACCME) has awarded Accreditation with Commendation—its highest level of accreditation—to the Heart Rhythm Society (HRS) for its continuing medical education (CME) programs. Under the updated 2006 Accreditation Criteria, approximately 21% of the providers reviewed to date have been awarded Accreditation with Commendation.